Nanotechnology-based devices in the treatment for Alzheimer’s disease

Chokkareddy, Rajasekhar; Thondavada, Niranjan; Kabane, Bakusele

doi:10.1016/b978-0-12-817923-9.00009-2

Nanomaterials in Diagnostic Tools and Devices 2020

DOI: 10.1016/b978-0-12-817923-9.00009-2

|View full text |Cite

Nanotechnology-based devices in the treatment for Alzheimer’s disease

Rajasekhar Chokkareddy

Niranjan Thondavada

Bakusele Kabane

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Bhattacharya

2023

CPB

View full text Add to dashboard Cite

Dementia impairs memory, critical thinking, and decision-making. Alzheimer’s disease is caused by extracellular amyloid fibrils containing the peptide Amyloid beta (Aβ) accumulating in the brain. Alzheimer’s disease is the most common form of dementia. A slew of small molecule inhibitors developed over several decades has targeted dementia and related diseases. The drugs and inhibitors cannot cross the BBB due to their insurmountable nature. Many molecular nanomedicines have been developed that can cross the BBB via adsorptive-mediated transcytosis. Drug-loaded nanosized formulations, such as polymeric nanoparticles, solid lipid nanotransporters, liposomes, nanoemulsions, exosomes, gold nanoparticles, and dendrimers, have a significant impact on dementia diagnosis and treatment. This review focuses on recent developments in nanotechnology-based drug delivery systems for dementia and related disorders such as Alzheimer’s disease. Recent advances in nanotechnology may help overcome drug delivery limitations for dementia therapy. Nanoparticles' size, composition, and structural variety bring up new therapeutic possibilities, including treating and diagnosing neurodegenerative diseases. It is possible to enhance therapeutic effectiveness by enhancing pharmacokinetics, bioavailability, water solubility, and stability under physiological conditions while reducing adverse effects by restricting their location in healthy tissues.

show abstract

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Bhattacharya

2023

CPB

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Nanotechnology-based devices in the treatment for Alzheimer’s disease

Cited by 1 publication

References 31 publications

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Contact Info

Product

Resources

About